Basics Gyre Therapeutics, Inc. IPO Date: August 21, 2015 Sector: Healthcare Industry: Biotech Market Cap: $767.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 3.86% Avg Daily Range (30 D): $0.51 | 5.25% Avg Daily Range (90 D): $0.49 | 5.09% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 264 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 117 Avg Inst. Trade: $1.58M Avg Inst. Trade (30 D): $1.14M Avg Inst. Trade (90 D): $1.38M Avg Inst. Trade Volume: .47M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.8M Avg Closing Trade (30 D): $1.59M Avg Closing Trade (90 D): $1.47M Avg Closing Volume: 587.36K     News Jun 10, 2025 @ 11:00 AM Gyre Therapeutics Announces First Dosing in Phase ... Source: N/A May 23, 2025 @ 12:57 AM Gyre Therapeutics Announces Pricing of $20.0 Milli... Source: N/A Jun 18, 2024 @ 8:05 PM Gyre Therapeutics Announces Publication in Journal... Source: Gyre Therapeutics, Inc. May 28, 2024 @ 8:05 PM Gyre Therapeutics Announces Expected Addition to t... Source: Gyre Therapeutics, Inc. May 9, 2024 @ 8:10 PM Gyre Therapeutics Reports First Quarter 2024 Finan... Source: Gyre Therapeutics, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $.03 $ $.14 Diluted EPS $ $ $.05 Revenue $ 22.06M $ 27.87M $ 105.76M Gross Profit $ 21.16M $ 26.7M $ 101.87M Net Income / Loss $ 3.73M $ .57M $ 17.9M Operating Income / Loss $ 2.27M $ .6M $ 16.16M Cost of Revenue $ .89M $ 1.18M $ 3.88M Net Cash Flow $ 3.18M $ -3.8M $ -21.42M PE Ratio     Splits Jan 13, 2023:   2:1 Feb 13, 2017:   1:15 Aug 21, 2015:   1:7